Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: diagnostic and therapeutic agents - Indi Molecular

Next Previous
Search
Drug Profile

Research programme: diagnostic and therapeutic agents - Indi Molecular

Alternative Names: Akt PCC; Akt specific branched peptide triligand - Caltech/Integrated Diagnostics; Protein catalysed capture agents - Indi Molecular

Latest Information Update: 25 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator California Institute of Technology/CalTech; Integrated Diagnostics
  • Class Diagnostic agents; Imaging agents; Peptides
  • Mechanism of Action Positron-emission tomography enhancers; Proto-oncogene protein c-akt inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 25 Aug 2023 Preclinical development of diagnostic and therapeutic agents is still ongoing for Cancer and Cancer (Diagnosis) in USA
  • 28 Dec 2019 No recent reports of development identified for preclinical development in Cancer in USA
  • 28 Dec 2019 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in USA

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top